Harold L. Klawans

9.2k total citations
210 papers, 6.9k citations indexed

About

Harold L. Klawans is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Harold L. Klawans has authored 210 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Neurology, 68 papers in Cellular and Molecular Neuroscience and 36 papers in Psychiatry and Mental health. Recurrent topics in Harold L. Klawans's work include Parkinson's Disease Mechanisms and Treatments (56 papers), Neurological disorders and treatments (55 papers) and Neurotransmitter Receptor Influence on Behavior (35 papers). Harold L. Klawans is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (56 papers), Neurological disorders and treatments (55 papers) and Neurotransmitter Receptor Influence on Behavior (35 papers). Harold L. Klawans collaborates with scholars based in United States, Israel and France. Harold L. Klawans's co-authors include William J. Weiner, Christopher G. Goetz, Paul A. Nausieda, Randi Rubovits, Caroline M. Tanner, William C. Koller, Paul M. Carvey, Richard B. Shekelle, George W. Paulson and Christopher G. Goetz and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.

In The Last Decade

Harold L. Klawans

205 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold L. Klawans United States 46 3.2k 2.7k 1.5k 1.1k 788 210 6.9k
H. Beckmann Germany 44 1.1k 0.3× 2.6k 1.0× 2.6k 1.8× 1.6k 1.5× 1.5k 1.9× 254 7.9k
E. Martignoni Italy 41 2.8k 0.9× 1.3k 0.5× 1.3k 0.9× 526 0.5× 733 0.9× 172 6.1k
Ubaldo Bonuccelli Italy 56 6.6k 2.1× 2.5k 0.9× 2.1k 1.4× 1.5k 1.4× 1.7k 2.1× 365 11.1k
Roberto Ceravolo Italy 49 4.3k 1.3× 1.8k 0.7× 843 0.6× 1.1k 1.0× 716 0.9× 275 8.2k
Elan D. Louis United States 49 4.1k 1.3× 1.5k 0.5× 1.1k 0.7× 918 0.9× 909 1.2× 135 6.9k
Peter A. LeWitt United States 48 5.0k 1.6× 2.1k 0.8× 620 0.4× 1.2k 1.1× 809 1.0× 200 8.1k
U. K. Rinne Finland 46 3.6k 1.1× 2.0k 0.7× 771 0.5× 905 0.9× 577 0.7× 228 6.2k
Jeffrey L. Cummings United States 34 2.1k 0.6× 796 0.3× 2.4k 1.6× 385 0.4× 1.2k 1.5× 53 5.8k
G M Stern United Kingdom 41 3.8k 1.2× 1.6k 0.6× 650 0.4× 641 0.6× 583 0.7× 111 5.7k
Erkka Syvälahti Finland 39 536 0.2× 2.5k 0.9× 1.8k 1.2× 1.1k 1.0× 1.2k 1.5× 134 5.4k

Countries citing papers authored by Harold L. Klawans

Since Specialization
Citations

This map shows the geographic impact of Harold L. Klawans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold L. Klawans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold L. Klawans more than expected).

Fields of papers citing papers by Harold L. Klawans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold L. Klawans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold L. Klawans. The network helps show where Harold L. Klawans may publish in the future.

Co-authorship network of co-authors of Harold L. Klawans

This figure shows the co-authorship network connecting the top 25 collaborators of Harold L. Klawans. A scholar is included among the top collaborators of Harold L. Klawans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold L. Klawans. Harold L. Klawans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olanow, C. Warren, Stanley Fahn, Manfred D. Muenter, et al.. (1994). A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease. Movement Disorders. 9(1). 40–47. 166 indexed citations
2.
Carvey, Paul M., et al.. (1993). Striatal Extracts from Patients with Parkinson's Disease Promote Dopamine Neuron Growth in Mesencephalic Cultures. Experimental Neurology. 120(1). 149–152. 42 indexed citations
3.
Vinken, Pierre J., G.W. Bruyn, Harold L. Klawans, & H L Frankel. (1992). Spinal cord trauma. Elsevier eBooks. 2 indexed citations
4.
Carvey, Paul M., et al.. (1991). Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Experimental Neurology. 114(1). 28–34. 20 indexed citations
5.
Klawans, Harold L.. (1991). Trials of an expert witness : tales of clinical neurology and the law. DigitalGeorgetown (Georgetown University Library). 1 indexed citations
6.
Goetz, Christopher G., Glenn T. Stebbins, Harold L. Klawans, et al.. (1990). Chapter 68 United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up. Progress in brain research. 82. 611–617. 16 indexed citations
7.
Carvey, Paul M., et al.. (1990). Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacology Biochemistry and Behavior. 35(2). 291–300. 22 indexed citations
8.
Tanner, Caroline M. & Harold L. Klawans. (1986). Tardive Dyskinesia. Clinical Neuropharmacology. 9. S76–S84. 2 indexed citations
9.
Nausieda, Paul A., et al.. (1982). Sleep Disruption in the Course of Chronic Levodopa Therapy. Clinical Neuropharmacology. 5(2). 183–194. 182 indexed citations
10.
Ing, Todd S., et al.. (1979). TOXIC EFFECTS OF AMANTADINE IN PATIENTS WITH RENAL FAILURE. InPharma. 184(1). 8–8. 37 indexed citations
11.
Sharf, B, et al.. (1978). Dream phenomena induced by chronic levodopa therapy. Journal of Neural Transmission. 43(2). 143–151. 89 indexed citations
12.
Weisdorf, Daniel J., Jeffrey A. Kramer, Alberto N. Goldbarg, & Harold L. Klawans. (1978). Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning. Clinical Pharmacology & Therapeutics. 24(6). 663–667. 11 indexed citations
13.
Nausieda, Paul A., et al.. (1978). Bromocriptine‐induced behavioral hypersensitivity. Neurology. 28(11). 1183–1183. 26 indexed citations
14.
Calne, Donald B. & Harold L. Klawans. (1977). Pathophysiology and pharmacotherapy of tremor. 2(1). 113–123. 6 indexed citations
15.
D’Amico, Donald J., et al.. (1976). The effect of methysergide on 5-hydroxytryptamine turnover in whole brain. Journal of Pharmacy and Pharmacology. 28(5). 454–456. 7 indexed citations
16.
Ostfeld, A M, Richard B. Shekelle, Harold L. Klawans, & Henry M. Tufo. (1974). Epidemiology of stroke in an elderly welfare population.. American Journal of Public Health. 64(5). 450–458. 56 indexed citations
17.
Weiner, William J., et al.. (1973). Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior. Journal of the Neurological Sciences. 20(4). 373–379. 40 indexed citations
18.
Klawans, Harold L., Donna Bergen, & G.W. Bruyn. (1973). Prolonged Drug-Induced Parkinsonism. Stereotactic and Functional Neurosurgery. 35(6). 368–377. 38 indexed citations
19.
Klawans, Harold L., et al.. (1972). Observations on the dopaminergic nature of hyperthyroid chorea. Journal of Neural Transmission. 33(1). 73–81. 47 indexed citations
20.
Ostfeld, A M, et al.. (1971). Cardiovascular and cerebrovascular disease in an elderly poor urban population.. American Journal of Public Health. 61(1). 19–29. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Beckmann Breakdown of academic impact, for papers by E. Martignoni Breakdown of academic impact, for papers by Ubaldo Bonuccelli Breakdown of academic impact, for papers by Roberto Ceravolo Breakdown of academic impact, for papers by Elan D. Louis Breakdown of academic impact, for papers by Peter A. LeWitt Breakdown of academic impact, for papers by U. K. Rinne Breakdown of academic impact, for papers by Jeffrey L. Cummings Breakdown of academic impact, for papers by G M Stern Breakdown of academic impact, for papers by Erkka Syvälahti
Rankless by CCL
2026